Literature DB >> 19367559

Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.

Stefania Varani1, Giada Frascaroli, Maria Paola Landini, Cecilia Söderberg-Nauclér.   

Abstract

Human cytomegalovirus (HCMV) infection is a major cause of morbidity and mortality in patients with an impaired immune system. The virus itself can cause transitory but significant immunosuppression in immunocompetent as well as immunocompromised infected individuals. Besides immunosuppression, HCMV-infected patients often develop other signs of immune dysfunction, such as autoimmune phenomena. Signs of active viral infection have also been identified in inflammatory lesions in a number of autoimmune diseases, highlighting the potential role of HCMV in the genesis or maintenance of such immunopathological phenomena. HCMV targets several cells of the immune system and subverts host immune functions to its own advantage. We present here an overview of the effects of HCMV infection on antigen-presenting cells and relate in vitro data to immunopathological findings in HCMV-infected patients. Possible mechanisms by which HCMV can induce host immunopathology will also be discussed. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19367559     DOI: 10.1002/rmv.609

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  17 in total

Review 1.  Cytomegalovirus: recent progress in understanding pathogenesis and control.

Authors:  V C Emery
Journal:  QJM       Date:  2011-12-22

Review 2.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 3.  Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Authors:  Shilpi Verma; Chris A Benedict
Journal:  J Interferon Cytokine Res       Date:  2011-01-12       Impact factor: 2.607

Review 4.  The roles of viruses in brain tumor initiation and oncomodulation.

Authors:  Alexander Kofman; Lucasz Marcinkiewicz; Evan Dupart; Anton Lyshchev; Boris Martynov; Anatolii Ryndin; Elena Kotelevskaya; Jay Brown; David Schiff; Roger Abounader
Journal:  J Neurooncol       Date:  2011-07-01       Impact factor: 4.130

5.  Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.

Authors:  Carina Bayer; Stefania Varani; Li Wang; Paul Walther; Shaoxia Zhou; Sarah Straschewski; Max Bachem; Cecilia Söderberg-Naucler; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

6.  Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients.

Authors:  Hsien-Jen Cheng; Yueh-Hsia Luo; Shu-Wen Wan; Chiou-Feng Lin; Shan-Tair Wang; Nguyen Thanh Hung; Ching-Chuan Liu; Tzong-Shiann Ho; Hsiao-Sheng Liu; Trai-Ming Yeh; Yee-Shin Lin
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

7.  Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta.

Authors:  Takako Tabata; Matthew Petitt; Martin Zydek; June Fang-Hoover; Nicholas Larocque; Mitsuru Tsuge; Matthew Gormley; Lawrence M Kauvar; Lenore Pereira
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

8.  The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

9.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

Review 10.  Alternatively activated macrophages in infection and autoimmunity.

Authors:  Delisa Fairweather; Daniela Cihakova
Journal:  J Autoimmun       Date:  2009-10-12       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.